About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 197 record(s)
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022
Req # A-2021-001637
All communications with airlines regarding vaccine exemptions for crew or travellers, between March 1 and November 30th, 2020.Organization: Health Canada
February 2022
Req # A-2021-001727
All documents associated Health Canada (HC) use of the hotel located at 640 Dixon Rd, Toronto, ON M9W 1J1 (aka Radisson Suite Hotel Toronto Airport): Leases, exhibits, and amendments HC has entered into with landlord Sunbridge Hotels (Square One)…Organization: Health Canada
February 2022
Req # A-2021-001745
The Screening Acceptance Letters from Health Canada to any and all generic drug manufacturer(s) confirming receipt of any and all Abbreviated New Drug Submissions for the combination of medicinal ingredients sulfamethoxazole and trimethoprim which…Organization: Health Canada
February 2022
Req # A-2021-001747
The Screening Acceptance Letters from Health Canada to any and all generic drug manufacturer confirming receipt of any and all Abbreviated New Drug Submissions for the medicinal ingredient degarelix acetate.Organization: Health Canada
February 2022
Req # A-2021-001754
Date range: October 1, 2019 to December 1, 2021. All contracts on file or entered into between the Government of Canada and ARBUTUS BIOPHARMA, Vancouver British Columbia (BC) and AQUITAS THERAPEUTICS, Vancouver BC.Organization: Health Canada
February 2022
Req # A-2021-001771
The final ministerial transition binder for Minister Bennett.Organization: Health Canada
February 2022
Req # A-2021-001803
In late 1999 and early 2000 there was a mould infestation at Long Lake #58 First Nation and Health Canada assigned Dr. Hari Mohan Vijay to the file. Dr. Vijay attended at the First Nation in either 2000 or 2001 and she conducted an investigation…Organization: Health Canada
February 2022
Req # A-2021-001806
Any abbreviated new drug submissions containing the medicinal ingredient methylphenidate hydrochloride in 10, 15, 20, 30, 40, 50, 60 or 80mg controlled release capsules submitted between June 23, 2021 and January 14, 2022.Organization: Health Canada
February 2022
Req # A-2021-001814
Information about when the drug RUZURGI was first available through Special Access Program (SAP). Specifically, when did Jacobus Pharmaceuticals start supplying RUZURGI (amifampridine) through SAP, and when was the date it was first available to…Organization: Health Canada
February 2022